Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Lemaitre

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|September 30, 2025
Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetesGabriele Sassi, Pierre Lemaitre, Laia Fernández Calvo, et al.
Diabetes|July 26, 2023
A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 DiabetesGabriele Sassi, Giada Licata, Giuliana Ventriglia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2006
New syndromic form of benign hereditary chorea is associated with a deletion of TITF-1 and PAX-9 contiguous genesDavid Devos, Isabelle Vuillaume, Alix de Becdelievre, et al.
Immunity|June 19, 2024
The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency programOliver T Burton, Orian Bricard, Samar Tareen, et al.
Diabetologia|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protectionLaure Degroote, Jędrzej Chrzanowski, Pierre Lemaitre, et al.
Cell|July 24, 2020
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult TransitionEmanuela Pasciuto, Oliver T Burton, Carlos P Roca, et al.
Nature Genetics|September 27, 2016
TSHZ3 deletion causes an autism syndrome and defects in cortical projection neuronsXavier Caubit, Paolo Gubellini, Joris Andrieux, et al.
European Journal of Medical Genetics|January 18, 2015
15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patientsClémence Vanlerberghe, Florence Petit, Valérie Malan, et al.
Science Advances|May 8, 2021
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cellsDespoina Kerselidou, Bushra Saeed Dohai, David R Nelson, et al.
Nature Immunology|May 26, 2022
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammationLidia Yshii, Emanuela Pasciuto, Pascal Bielefeld, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|September 30, 2025
Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetesGabriele Sassi, Pierre Lemaitre, Laia Fernández Calvo, et al.
Diabetes|July 26, 2023
A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 DiabetesGabriele Sassi, Giada Licata, Giuliana Ventriglia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2006
New syndromic form of benign hereditary chorea is associated with a deletion of TITF-1 and PAX-9 contiguous genesDavid Devos, Isabelle Vuillaume, Alix de Becdelievre, et al.
Immunity|June 19, 2024
The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency programOliver T Burton, Orian Bricard, Samar Tareen, et al.
Diabetologia|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protectionLaure Degroote, Jędrzej Chrzanowski, Pierre Lemaitre, et al.
Cell|July 24, 2020
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult TransitionEmanuela Pasciuto, Oliver T Burton, Carlos P Roca, et al.
Nature Genetics|September 27, 2016
TSHZ3 deletion causes an autism syndrome and defects in cortical projection neuronsXavier Caubit, Paolo Gubellini, Joris Andrieux, et al.
European Journal of Medical Genetics|January 18, 2015
15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patientsClémence Vanlerberghe, Florence Petit, Valérie Malan, et al.
Science Advances|May 8, 2021
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cellsDespoina Kerselidou, Bushra Saeed Dohai, David R Nelson, et al.
Nature Immunology|May 26, 2022
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammationLidia Yshii, Emanuela Pasciuto, Pascal Bielefeld, et al.
Pageof 2